ConductScience.org, home

Paper35898461

Incidence, Morbidity and years Lived With Disability due to Type 2 Diabetes Mellitus in 204 Countries and Territories: Trends From 1990 to 2019.

Zhu R and 3 others. Front Endocrinol (Lausanne), 2022. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Incidence, Morbidity and years Lived With Disability due to Type 2 Diabetes Mellitus in 204 Countries and Territories: Trends From 1990 to 2019. Papers, record 35898461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35898461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence, Morbidity and years Lived With Disability due to Type 2 Diabetes Mellitus in 204 Countries and Territories: Trends From 1990 to 2019.
PubMed
Journal
Front Endocrinol (Lausanne)
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
3.23
iCite
Revised in PubMed
2025-07-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu RRongrong
2Zhou SShan
3Xia LLiang
4Bao XXiaoming

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Global Burden of DiseaseMajor topic
Disability-Adjusted Life Years
Global Health
Humans
Incidence
Morbidity
Quality-Adjusted Life Years

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131492503Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.Lancet2020https://conductscience.org/library/papers/31492503PubMed
227159875Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.Endocr Rev2016https://conductscience.org/library/papers/27159875PubMed
329780358Sex and Gender Differences in Prevention of Type 2 Diabetes.Front Endocrinol (Lausanne)2018https://conductscience.org/library/papers/29780358PubMed
434732399Secular incidence trends and effect of population aging on mortality due to type 1 and type 2 diabetes mellitus in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019.BMJ Open Diabetes Res Care2021https://conductscience.org/library/papers/34732399PubMed
533911959Association between self-care management practices and glycemic control of patients with type 2 diabetes mellitus in Saud Arabia: A cross -sectional study.Saudi J Biol Sci2021https://conductscience.org/library/papers/33911959PubMed
632529512Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies.Eur J Epidemiol2020https://conductscience.org/library/papers/32529512PubMed
734399949An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective.Endocrinol Metab Clin North Am2021https://conductscience.org/library/papers/34399949PubMed
834321515Trends in type 2 diabetes mellitus disease burden in European Union countries between 1990 and 2019.Sci Rep2021https://conductscience.org/library/papers/34321515PubMed
933486878Measuring the global, regional, and national burden of type 2 diabetes and the attributable risk factors in all 194 countries.J Diabetes2021https://conductscience.org/library/papers/33486878PubMed
1030193830Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants.Lancet Glob Health2018https://conductscience.org/library/papers/30193830PubMed
1133069326Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet2020https://conductscience.org/library/papers/33069326PubMed
1222221213Global nutrition transition and the pandemic of obesity in developing countries.Nutr Rev2012https://conductscience.org/library/papers/22221213PubMed
1331176961Secular trends in incidence and mortality of bladder cancer in China, 1990-2017: A joinpoint and age-period-cohort analysis.Cancer Epidemiol2019https://conductscience.org/library/papers/31176961PubMed
1432175717Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.J Epidemiol Glob Health2020https://conductscience.org/library/papers/32175717PubMed
1535012503Time trends in type 2 diabetes mellitus incidence across the BRICS from 1990 to 2019: an age-period-cohort analysis.BMC Public Health2022https://conductscience.org/library/papers/35012503PubMed
1629877150Overview of trends in cardiovascular and diabetes risk factors in Fiji.Ann Hum Biol2018https://conductscience.org/library/papers/29877150PubMed
1730496104
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet2018https://conductscience.org/library/papers/30496104PubMed
1833069325
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
Lancet2020https://conductscience.org/library/papers/33069325PubMed
1932901098Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025.Sci Rep2020https://conductscience.org/library/papers/32901098PubMed
2028422124Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.Eur J Clin Nutr2017https://conductscience.org/library/papers/28422124PubMed

See all 26 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42953516
Global Burden, Temporal Trends, Extrapolation Based on Past Trends, and Population Attributable Fractions of Risk Factors for Type 2 Diabetes Mellitus: An Ecological Study Based on the Global Burden of Disease Study 2021.
Health Sci Rep2026https://conductscience.org/library/papers/42953516PubMed
42793011Effect-Allele Frequencies at Cardiometabolic Risk Loci in an Uzbek Cohort from Tashkent: A Central Asian Reference and Priorities for Polygenic Score Validation.Genes (Basel)2026https://conductscience.org/library/papers/42793011PubMed
42658661Unmasking Type 2 Diabetes in an Aging Mexico: Trends and Disparities by Sex and State-Level From the GBD 2021 Study.J Diabetes Res2026https://conductscience.org/library/papers/42658661PubMed
42487877Short-Term Glycemic Outcomes Associated with Imeglimin Use Among Patients with Type 2 Diabetes Mellitus: A Prospective Observational Study.Drug Des Devel Ther2026https://conductscience.org/library/papers/42487877PubMed
41587125Type 2 Diabetes Risk among Incident Parkinson's Disease Patients: A 20-Year Retrospective Population-Based Cohort Study.Neuroepidemiology2026https://conductscience.org/library/papers/41587125PubMed
41522419Comparison of Urine pH in Postmenopausal Women With a Current, a History of, or No History of Uncomplicated Urinary Tract Infection.JU Open Plus2026https://conductscience.org/library/papers/41522419PubMed
41127534Changes and Diagnostic Value of Serum CCL26 and CCR3 in T2DM with Lower Extremity Artery Disease.Vasc Health Risk Manag2025https://conductscience.org/library/papers/41127534PubMed
41080431Effects of integrated care on health outcomes in patients with diabetes in primary healthcare: A systematic review and meta-analysis protocol.MethodsX2025https://conductscience.org/library/papers/41080431PubMed
40943569
Frequency of Polymorphisms in SLC47A1 (rs2252281 and rs2289669) and SLC47A2 (rs34834489 and rs12943590) and the Influence of SLC22A1 (rs72552763 and rs622342) on HbA1c Levels in Mexican-Mestizo Patients with DMT2 Treated with Metformin Monotherapy.
Int J Mol Sci2025https://conductscience.org/library/papers/40943569PubMed
40900212Treatment outcomes and safety profile of SGLT2 inhibitors versus GLP-1 agonists in type 2 diabetes mellitus : Systematic review of real-world observational studies.Wien Med Wochenschr2026https://conductscience.org/library/papers/40900212PubMed
40895618Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021, with forecasts to 2050.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40895618PubMed
40890864Serum copper modulates cognitive function in diabetic patients via an HDL-C-mediated pathway: identification of a 25 µg/dL exploratory threshold.Diabetol Metab Syndr2025https://conductscience.org/library/papers/40890864PubMed
40809839Epidemiological Study of Childhood Idiopathic Epilepsy from 1990 to 2021 at Global, Regional, and National Scales.Mayo Clin Proc Innov Qual Outcomes2025https://conductscience.org/library/papers/40809839PubMed
40791828Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021.Ther Adv Endocrinol Metab2025https://conductscience.org/library/papers/40791828PubMed
40290999Activation of the Insulin Receptor by Sarcopoterium spinosum Extract and Identification of Sarcocyanidin A as a Novel Active Compound.ACS Omega2025https://conductscience.org/library/papers/40290999PubMed
40140909Rising tide: the growing global burden and inequalities of early-onset type 2 diabetes among youths aged 15-34 years (1990-2021).Diabetol Metab Syndr2025https://conductscience.org/library/papers/40140909PubMed
40068620Global, Regional, and National Temporal Trends in Incidence for Type 2 Diabetes Mellitus Related Chronic Kidney Disease from 1992 to 2021.Diabetes Metab J2025https://conductscience.org/library/papers/40068620PubMed
39718116Association of constipation with all-cause mortality among individuals with type 2 diabetes: A retrospective cohort study.J Diabetes Investig2025https://conductscience.org/library/papers/39718116PubMed
39620331Effectiveness and Safety of Metformin, Teneligliptin, and Glimepiride Combination Therapy in Type 2 Diabetes: A Quasi Experimental Clinical Trial.Curr Diabetes Rev2025https://conductscience.org/library/papers/39620331PubMed
39478615Mortality from type 2 diabetes mellitus across municipalities in Mexico.Arch Public Health2024https://conductscience.org/library/papers/39478615PubMed

See all 30 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35898461

GET https://conductscience.org/api/papers/v1/35898461/references?page=2